Management of multiple myeloma in Asia: resource-stratified guidelines
- Authors
- Tan, Daryl; Chng, Wee Joo; Chou, Takaaki; Nawarawong, Weerasak; Hwang, Shang-Yi; Chim, Chor Sang; Chen, Wenming; Durie, Brian G. M.; Lee, Jae Hoon
- Issue Date
- Nov-2013
- Publisher
- ELSEVIER SCIENCE INC
- Citation
- LANCET ONCOLOGY, v.14, no.12, pp.E571 - E581
- Journal Title
- LANCET ONCOLOGY
- Volume
- 14
- Number
- 12
- Start Page
- E571
- End Page
- E581
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14152
- DOI
- 10.1016/S1470-2045(13)70404-2
- ISSN
- 1470-2045
- Abstract
- Treatment of multiple myeloma has undergone substantial developments in the past 10 years. The introduction of novel drugs has changed the treatment of the disease and substantially improved survival outcomes. Clinical practice guidelines based on evidence have been developed to provide recommendations on standard treatment approaches. However, the guidelines do not take into account resource limitations encountered by developing countries. The huge disparities in economy, health-care infrastructure, and access to novel drugs in Asian countries hinder the delivery of optimum care to every patient with multiple myeloma in Asia. In this Review we outline the guidelines that correspond with different levels of health-care resources and expertise, with the aim to unify diagnostic and therapeutic guidelines and help with the design of future studies in Asia.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14152)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.